BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.
Our focus on scientific excellence and rapid execution aim to translate today's discoveries into tomorrow's medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe.
The Director, KOL Management will support the development of a late-stage commercial asset, Acoramidis, for ATTR-cardiomyopathy. The individual will drive cross-functional collaboration and tactical alignment, ensuring success in the U.S. and across the globe. They will lead the development of assessment, strategic and tactical development, and engagement with key opinion leaders in this space. Success will be measured by gaining and sharing key insights, developing knowledge related to an asset and/or disease state, and developing mutually beneficial partnerships with relevant stakeholders.
This person will lead a strategic role on commercial global product teams and work closely with Market Insights, Development, Regulatory, Medical Affairs, and other key stakeholders. The position requires excellent communication skills, leadership, and a proven ability to influence the organization. Candidates should feel at home in a fast-paced environment. This role will report to the Sr. Director, HCP Marketing.
ResponsibilitiesDesign KOL identification/profiling, mapping, and critical strategic efforts to establish engagement with and by KOLs in the cardiology space.Lead the creation, execution, and maintenance of the commercial Key Opinion Leader engagement plan to build, cultivate, and maintain KOL relationships.Develop resources for KOL engagement activities, such as a database or similar platform for tracking KOL partnership.Collaborate to develop and manage the Acoramidis speaker bureau, inclusive of program structure/development/maintenance, speaker selection, and innovative approaches to further brand messaging.Partner closely with internal teams to ensure we are using appropriate insights and metrics to inform the KOL management strategy and activities.Lead the development and execution of commercial advisory boards to inform, uncover opportunities and support brand strategy and launch preparation.Liaise and communicate with internal stakeholders, including medical affairs and product development, and advisory board insights to ensure aligned understanding and implementation.Proactively evaluate/assess the relevant market landscape, monitoring changes in market dynamics, competition, clinician needs, and practices.Develop targeted measurement plans – setting goals and meeting KPIs.Work cross-functionally with agency partners, sales, commercial operations, brand analytics, I.T., MCM, etc.No matter your role at BridgeBio, successful team members are: Patient Champions, who put patients first and uphold strict ethical standards.Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset.Truth Seekers, who are detailed, rational, and humble problem solvers.Individuals Who Inspire Excellence in themselves and those around them.High-quality executors, who execute against goals and milestones with quality, precision, and speed.Education, Experience & Skills Requirements7+ years of industry experience (sales/marketing, clinical practice, academic, and/or medical affairs).Field-based experience is preferred but not required.Cardiovascular experience is preferred but not required.Experience leading KOL engagement activities, including the management of KOL data and implementation of strategic initiatives.High-level strategic thinking, with the ability to translate customer insights into actionable marketing strategy and to align with critical stakeholders on operational priorities.Proven self-starter, able to work independently and as part of a team.Able to handle full workload across multiple projects.Collaborates seamlessly across functions to build effective working relationships and align on strategy and execution.Proven track record of solid strategic leadership, teamwork, innovation, and project management and demonstrated ability to manage, lead, and mentor individuals.Successful launch experience in a competitive market preferred.Excellent oral, written, and presentation skills.High level of self-awareness and understanding of the importance of self-monitoring behavior for continuous improvement.True entrepreneurial spirit – BridgeBio was built to do things differently and address the needs of underserved populations, driven by science and unrelenting passion for patients.30-40% travel anticipated for conference attendance, KOL meetings, speaker program attendance, etc. (expected to be on the higher end, 40%+, during initial launch preparation).What We OfferPatient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts.A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak.An unyielding commitment to always putting patients first.A de-centralized model that enables our program teams to focus on advancing science and helping patients.A place where you own the vision – both for your program and your own career path.A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game.Access to learning and development resources to help you get in the best professional shape of your life.Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs).Flexible PTO.Rapid career advancement for strong performers.Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time.Commitment to Diversity, Equity & Inclusion.
#J-18808-Ljbffr